10 questions lodged at 2022 Polynovo AGM

October 30, 2022

Here is the text of 10 written questions lodged at the 2022 Polynovo hybrid AGM held on October 28. The majority, which are italicised, were censored and not asked.

The formal addresses lodged with the ASX this morning were only 5 pages. Given the depth and breadth of the discussion, could you please publish a full transcript of today's AGM, plus provide access to the full webcast?

Why does chair David Williams keep on buying shares in small parcels, generating dozens of ASX announcements about his increased investment. We know you support the stock and are fully invested. There is no need to ride every dip in such a high profile look at me way. If this is going to keep up, roughly how much does David have pencilled in to spend buying Polynovo shares between now and next year's AGM.

Did any of the 5 main proxy advisers - ACSI, Ownership Matters, Glass Lewis, ISS and ASA - recommend a vote against any of today's resolutions. Which of the proxy advisers are covering us and has their been a material proxy protest vote against any of today's resolutions? Will you disclose the proxy votes before the debate on today's resolutions so shareholders can ask questions about the reasons if there have been any protest votes? Also, next year will you join the growing trend of companies disclosing the proxy position to the ASX with the formal addresses ahead of the AGM commencing?

How much time is chair David Williams spending on Polynovo and roughly what proportion of his net wealth is tied up in his current shareholding at $1.94. Yesterday he was busily throwing rocks at another listed company, Globe International, triggering a second strikes on its rem report and voting his personal holding in favour of a distracting but pointless board spill. As a shareholder in both Globe and Polynovo, I would prefer our chairman provides support and encouragement for Globe, rather than joining Solomon Lew's pointless 20 year war against the company. Can he comment on just how focused he is on Polynovo versus other ventures and activist campaigns.

Which of our major institutional shareholders are lending their Polynovo shares to allow 11.5% of it to be short? And do you know the identify of any hedge funds that have been shorting our stock. Have any of them tried to distribute misinformation or rumors via HotCopper or the mainstream media to drive the shares down?

The US health care sector is notoriously corrupt with all sorts of kick backs, influencing plays, conflicts of interest, heavy politics, powerful professional bodies, overpaid health insurers and multinational giants that spray cash and influence all over the shop. Have we been surprised or taken aback by any of the market practices we've encountered in the US. What are the biggest differences between market access challenges in the US compared with Australia and Europe? Have we had to make any ethical or integrity calls whilst operating in that market?

Could Leon comment on whether it would be more appropriate if Polynovo had an independent chairman, rather than David Williams who is more like an executive chairman and is not really independent given the size of his shareholding. Can we at least appoint a deputy chair?

There was a 10% vote against this options grant? Did one of the proxy advisers recommend against and what was the issue?

There was a 24% protest vote against the rem report. Did David Williams vote? Are we going to adjust the vesting period?

Is it appropriate for the chair to vote undirected proxies in favour of the rem report when it is so close to the 25% strike threshhold? Also, please stop being so rude to the ASA.